Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.09

(-2.18%)

FLWS

$3.72

(0%)

ACCO

$3.81

(-0.78%)

ARLP

$24.34

(-0.27%)

AUIAF

$0.17

(0%)

AZZ

$137.3

(-4.23%)

BTBT

$1.73

(3.29%)

BTM

$0.49

(0%)

CVKD

$3.1

(0.16%)

LCE:CA

$0.28

(0%)

COCP

$1.01

(2.65%)

CDRO

$9.53

(0.32%)

CVGI

$5.07

(4.32%)

LODE

$4.14

(0.98%)

CMTL

$1.99

(2.32%)

CNDT

$1.51

(-0.98%)

CXW

$30.73

(0.38%)

CMLS

$0.01

(0%)

DRCT

$2.66

(0%)

DLHC

$5.17

(0%)

SSP

$3.13

(-0.48%)

ELDN

$4.17

(-0.97%)

EVC

$11.95

(2.05%)

EDRY

$22

(-0.36%)

ESEA

$70.51

(1.91%)

FAT

$0.16

(0%)

RAIL

$8.35

(2.45%)

GDEV

$13.16

(9.76%)

GOVX

$1.16

(0%)

GOCO

$0.3

(0%)

GHM

$111.24

(4.3%)

GLDD

$17

(0%)

GYRE

$7.58

(-1.88%)

HMENF

$1.82

(0%)

III

$4.01

(-0.99%)

IPOOF

$10.4

(0%)

KELYA

$13.21

(-0.79%)

KTOS

$49.8

(-1.16%)

LUCK

$7.29

(3.26%)

MAIA

$1.45

(-1.69%)

MGROF

$0.25

(0%)

NTRB

$3.1

(1.31%)

OCGN

$1.47

(-2.33%)

PERF

$1.75

(0%)

QMCI

$0.15

(0%)

RGP

$4.62

(0.22%)

SGA

$9.06

(1.68%)

SHWZ

(0%)

SHIP

$14.2

(-1.87%)

SLQT

$0.76

(-1.55%)

SKYX

$1.17

(-1.27%)

SNAL

$4.04

(-0.37%)

GEO

$29.84

(0.62%)

ODP

$28

(0%)

TNXP

$12.5

(-2.19%)

TSQ

$6.74

(0.75%)

TZOO

$10.88

(0.88%)

UNCY

$5.34

(-1.57%)

VVX

$76.62

(-0.25%)

VNCE

$6.6

(0%)

XELB

$1.49

(0.97%)

ZOMDF

$0.09

(-2.18%)

FLWS

$3.72

(0%)

channelchek-in

‌

7/8/2026

Chemomab and Scipher Merge to Bring AI-Guided Precision Medicine to Rheumatoid Arthritis

Two small-cap biotechs are betting that artificial intelligence can succeed where a decade of drug development has stalled. Chemomab Therapeutics (Nasdaq: CMMB) and Scipher Medicine announced this morning that they have entered into a definitive merger agreement, combining Chemomab’s clinical-stage antibody nebokitug with Scipher’s AI-powered precision medicine platform to attack rheumatoid arthritis from a completely different angle than anything currently on the market.

3 min read